Abstract
Abstract Objective: Hypertension (HTN) represents a public health problem and blood pressure (BP) control rates have remained poor worldwide leading to an increasing number of hospital admission. The purpose of the current study is to describe the pattern of anti-HTN drug therapy in the Department of Internal Medicine of a tertiary care emergency hospital. Design and method: We retrospectively analysed all the charts of patients admitted for HTN in the Internal Medicine department of a tertiary care emergency hospital during 3 months (August-October 2019). We retrieved demographic, clinical and treatment approach data from the charts of patients presenting for HTN defined as JOURNAL/jhype/04.03/00004872-202104001-00695/inline-graphic1/v/2024-05-27T045911Z/r/image-tiff . We compared different characteristics between female patients (FM) and male (ML) patients. Results: 69 patients admitted for HTN in 3 months (4.64% from all admissions), 43 female patients (62.3%) mean age 65.51±1.41. The FM, when compared with ML, were more frequently older, with a higher mean systolic BP with the same mean diastolic BP. The calcium channel blockers were more frequently use in female than in their male counterparts, the same use of angiotensin-converting-enzyme inhibitors (ACEi), angiotensin -receptor-blockers (ARB), Loop diuretics and beta blocker was preferred as antihypertensive drug medication in male. See table. Conclusions: Hypertensive disease remains one of the main causes for hospital admission. Patients are more frequently women, have an advanced age, a higher systolic blood pressure making them more likely to have a more severe clinical picture. ACEI, CCB, and beta blocker are the preferred antihypertensive therapy. The number of patients with HTN is the expected to rise with the increase life expectancy if a correct antihypertensive therapy is not applied.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.